LENZ Therapeutics Ownership | Who Owns LENZ Therapeutics?

LENZ Therapeutics Ownership Summary

LENZ Therapeutics is owned by 73.10% institutional investors, 2.82% insiders, and 24.08% retail investors.

LENZ Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	LENZ Therapeutics	73.10%	2.82%	24.08%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	93	19.23%	19,863,813	6.02%	73	1.54%	56	30.23%	20	25.00%
Sep 30, 2024	78	23.81%	18,735,645	-0.94%	68	1.26%	43	-4.44%	16	300.00%
Jun 30, 2024	63	14.55%	18,913,542	16.53%	73	1.84%	45	-18.18%	4	-
Mar 31, 2024	55	-	16,230,517	-	63	-	55	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 14, 2024	Chevallard Daniel R.	Chief Financial Officer	Buy	$49.99K
May 13, 2024	MCCOLLUM JAMES W	-	Buy	$501.09K
Mar 21, 2024	RA CAPITAL MANAGEMENT, L.P.		Buy	$14.02M
Mar 21, 2024	RA CAPITAL MANAGEMENT, L.P.		Buy	$976.51K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	2	-

LENZ Ownership FAQ

Who Owns LENZ Therapeutics?

LENZ Therapeutics shareholders are primarily institutional investors at 73.10%, followed by 2.82% insiders and 24.08% retail investors. The average institutional ownership in LENZ Therapeutics's industry, Biotech Stocks , is 68.48%, which LENZ Therapeutics exceeds.

Does Blackrock own LENZ Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LENZ Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools